Prototype Web Portal Shows Technology’s Potential to Protect and Streamline the Clinical Trials Process
UC San Francisco researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain. The system creates an immutable audit trail that makes it easy to spot any tampering with results—such as making the treatment look more effective or diminishing side effects.
“Everyone is talking about how blockchain is going to revolutionize many of the data challenges in medicine, and here is one use that finally might make sense,” said Atul Butte, MD, PhD, who is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and director of the Bakar Computational Health Sciences Institute at UCSF. “We think it could someday be useful for pharma companies running clinical trials.”
The research was published February 22 in Nature Communications.
Blockchain technology utilizes an old computer science technique known as hashing, which creates a unique digital signature for each so-called block of data. The hashes accumulate sequentially, as new data is entered or changed, with each block depending on the last. The resulting “blockchain” creates an audit trail for regulators that is easy to decipher and validate, even without looking at the actual data.
Daniel Wong, a PhD candidate in Biological and Medical Informatics at UCSF, built the system to operate through a web portal, so that each time new data is entered on a given trial participant, the sender, receiver, timestamp, and file attachment containing the data, along with the hash of the previous block of data pertaining to that patient, is recorded onto a new block, with its own distinct signature.
Unlike the decentralized nature of most blockchain applications, this clinical trial prototype depends on having a regulator with centralized authority, such as the U.S. Food and Drug Administration, to operate the web portal, register all parties, and keep a ledger of the blockchain’s hashes.
Data, including adverse events, would be reported to the regulatory agency in real time, which may provide a boost to the safety and efficiency of clinical trials. While the prototype makes allowances for data entry or other errors to be corrected, new data can only be appended to the existing chain, without erasing what was there before.
“It makes it really obvious when someone’s changing something,” Wong said. “You can see who put their hands on it, who made it, who changed it, and who received it.”
Wong tested the system with a small subset of data from a real, previously run phase II trial included in ImmPort, a repository of open clinical trial data funded by the National Institutes of Allergy and Infectious Diseases (NIAID) that is managed by Butte’s lab and collaborators.
After entering the original data, he logged in as the trial sponsor and tried to erase adverse events that had been reported for two patients in their case report forms. Instead of deleting those reports, however, the system appended his changes to the original data, making it clear who had tried to corrupt the forms, when it was done, and what had been changed.
Wong also tried corrupting the data stored from an earlier point in the trial, when patients were assigned to different treatment arms—drug or placebo—to make it look as though they had been given a different medication plan. But the blockchain ledger pinpointed exactly what had changed and when.
A prototype system like this reduces risks, but does not completely protect data from tampering. Even within a system enabled with this type of blockchain technology, the authors pointed out, it is still possible that those seeing patients at the point of care could enter wrong or incorrect data at the outset.
But blockchain technology could enable trials to be conducted under challenging conditions, or open doors to data exchanges that are more secure, more efficient, and more transparent for both researchers and the general public.
“A system built upon our prototype could be developed to enable oversight of international clinical trials, for example,” Butte said. “And it could be expanded to provide more access to raw data for research scientists, the way we do with ImmPort, or deliver trial results to the public.”
Learn more: Could Blockchain Ensure Integrity of Clinical Trial Data?
The Latest on: Blockchain
[google_news title=”” keyword=”blockchain” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Blockchain
- Could Blockchain Change How eBook Ownership Works?on April 27, 2024 at 12:41 am
The Bitcoin price increase, seen easily on the Binance website, has catalyzed a renaissance of interest in blockchain technology, highlighting its potential beyond cryptocurrencies. Blockchain, the ...
- Blockchain Firm Movement Labs Celebrates $38M Series Aon April 26, 2024 at 2:15 pm
Movement Labs, a San Francisco-based blockchain development team, has secured $38 million in a Series A financing round led by Polychain Capital. The funding ...
- Solana: The blockchain speedster that's making waveson April 26, 2024 at 11:12 am
But that same sense of frustration has plagued the world of blockchain technology, where slow transaction speeds have been a major hurdle to adoption. Enter Solana, the blockchain that's aiming to ...
- OneWorldChain Launches Its Revolutionary OWCT Token, Initiating a New Era in Blockchain Technologyon April 26, 2024 at 11:05 am
OneWorldChain launches OWCT token, enhancing blockchain with high-speed, low-cost transactions; Mainnet live, tokens available July 2024.
- From Blockchain to Bitcoin: How Cryptocurrency is Changing the Face of Financeon April 26, 2024 at 10:56 am
In a world where traditional banking systems are being disrupted at every turn, the rise of cryptocurrency has taken the financial industry by storm. From blockchain technology to the ever-popular ...
- Movement Labs raises $38M to add Facebook’s Move to Ethereum blockchainon April 26, 2024 at 9:56 am
San Francisco-based blockchain development team Movement Labs announced Thursday it has raised $38 million in Series A funding to support the company’s work to bring Facebook’s Move language virtual ...
- Exploring the Impact of Blockchain in Advertisingon April 26, 2024 at 9:23 am
From combating ad fraud to revolutionizing data privacy, the applications of blockchain in advertising are vast and transformative. Let’s delve deeper into how this innovative technology is reshaping ...
- Why Are Bitcoin Ordinals Important Assets for Blockchain?on April 26, 2024 at 8:10 am
Bitcoin Ordinals have marked an important milestone in the evolution of digital assets, which have brought new possibilities for Bitcoin.
- FAIRWINDS Credit Union Joins Metal Blockchain's Banking Innovation Programon April 25, 2024 at 10:44 am
Exploring Blockchain Use Cases for Enhanced Financial Services. San Francisco - April 25, 2024 — Metallicus, the core developer of Metal ...
- Movement Labs raises $38 million to build layer-2 blockchain on Ethereum with Facebook techon April 25, 2024 at 7:45 am
Polychain led the Series A funding round, which included participation from Hack VC, dao5, and Robot Ventures.
via Bing News